InformationOsimertinib (AZD9291) is an oral, irreversible, and mutant-selectiveEGFRinhibitor withIC50of 12.92, 11.44 and 493.8 nM for Exon 19 deletion EGFR, L858R/T790M EGFR, and WT EGFR in LoVo cells, respectively. Phase 3.In vitroAZD9291 shows significantly more potent inhibition of proliferation in mutant EGFR cell lines compared to wild-type in vitro.In vivoAZD9291(5mg/kg p.o.) causes profound regression of tumors across EGFRm+ (PC9) and EGFRm+/T790M (H1975) tumor models with profound inhibition of EGFR phosphorylation and key downstream signaling pathways such as AKT and ERK in vivo.Cell Datacell lines:HUVECsConcentrations:Incubation Time:Powder Purity:≥99%.
Specifications and Purity: 10mM in DMSO
Molecular Formula: C28H33N7O2
Molecular Weight: 499.61
- UPC:
- 10161614
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- O408946-1ml
- CAS:
- 1421373-65-0
- Product Size:
- 1ml
akash.verma@cenmed.com
(732) 447-1115





